Universe Pharmaceuticals (UPC) Equity Ratio (2020 - 2025)
Universe Pharmaceuticals' Equity Ratio history spans 6 years, with the latest figure at 0.81 for Q3 2025.
- On a quarterly basis, Equity Ratio rose 20.95% to 0.81 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.81, a 20.95% increase, with the full-year FY2025 number at 0.81, up 20.95% from a year prior.
- Equity Ratio hit 0.81 in Q3 2025 for Universe Pharmaceuticals, up from 0.67 in the prior quarter.
- Over the last five years, Equity Ratio for UPC hit a ceiling of 670.35 in Q3 2023 and a floor of 0.54 in Q1 2024.
- Historically, Equity Ratio has averaged 158.5 across 5 years, with a median of 0.74 in 2025.
- Biggest five-year swings in Equity Ratio: tumbled 100.0% in 2021 and later surged 88474.92% in 2022.
- Tracing UPC's Equity Ratio over 5 years: stood at 0.67 in 2021, then surged by 88474.92% to 593.39 in 2022, then grew by 12.97% to 670.35 in 2023, then plummeted by 99.9% to 0.67 in 2024, then grew by 20.95% to 0.81 in 2025.
- Business Quant data shows Equity Ratio for UPC at 0.81 in Q3 2025, 0.67 in Q3 2024, and 0.54 in Q1 2024.